Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.
To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.
Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
Evolus (EOLS) – This company develops aesthetic medical products. Today, Barclays analyst Balaji Prasad maintained a Buy rating on the stock with a price target of $20. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 41%.
Aura Biosciences (AURA) – Aura is a biotechnology company that develops treatments for life-threatening cancers, particularly in the eye. Today, JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on the stock with a price target of $23. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Altogether, their 12-month price targets imply an upside of about 115%.
Delta Air Lines (DAL) – This is one of the major airlines in the United States. Today, Barclays analyst Brandon Oglenski maintained a Buy rating on the stock with a price target of $52. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 30%.
Who Are the Top Analysts?
TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time.
See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page.
